dawn: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Cash provided by financing activities	748	748
Net (decrease) increase in cash and cash equivalents	-81,691	-89,346
Cash and cash equivalents at beginning of period	124,968	-
Cash and cash equivalents at end of period	43,277	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Cash provided by financing activities	748	748
Net (decrease) increase in cash and cash equivalents	-81,691	-89,346
Cash and cash equivalents at beginning of period	124,968	-
Cash and cash equivalents at end of period	43,277	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Day One Biopharmaceuticals, Inc. (DAWN)